ZNF563
gene geneOn this page
Also known as FLJ34797
Summary
ZNF563 (zinc finger protein 563, HGNC:30498) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 563 (Q8TA94). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 147837 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 87 total
- MANE Select transcript:
NM_145276
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30498 |
| Approved symbol | ZNF563 |
| Name | zinc finger protein 563 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ34797 |
| Ensembl gene | ENSG00000188868 |
| Ensembl biotype | protein_coding |
| Entrez | 147837 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
ENST00000293725, ENST00000594577, ENST00000595977, ENST00000601858, ENST00000873252
RefSeq mRNA: 2 — MANE Select: NM_145276
NM_001363608, NM_145276
CCDS: CCDS12270, CCDS86706
Canonical transcript exons
ENST00000293725 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001185291 | 12317477 | 12319833 |
| ENSE00001727359 | 12321272 | 12321332 |
| ENSE00001831571 | 12333480 | 12333633 |
| ENSE00003661839 | 12322585 | 12322711 |
Expression profiles
Bgee: expression breadth ubiquitous, 173 present calls, max score 85.84.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.2155 / max 133.7604, expressed in 1288 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179300 | 1.6820 | 644 |
| 179301 | 0.8778 | 446 |
| 179303 | 0.6848 | 426 |
| 179302 | 0.6219 | 366 |
| 179299 | 0.3098 | 149 |
| 179298 | 0.0392 | 11 |
Top tissues by expression
225 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.84 | gold quality |
| left testis | UBERON:0004533 | 79.55 | gold quality |
| calcaneal tendon | UBERON:0003701 | 78.67 | gold quality |
| right testis | UBERON:0004534 | 78.32 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.97 | gold quality |
| testis | UBERON:0000473 | 77.31 | gold quality |
| right lobe of liver | UBERON:0001114 | 76.05 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 73.42 | gold quality |
| right atrium auricular region | UBERON:0006631 | 73.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 72.90 | gold quality |
| cardiac atrium | UBERON:0002081 | 72.33 | gold quality |
| apex of heart | UBERON:0002098 | 72.15 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 72.12 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 71.28 | gold quality |
| islet of Langerhans | UBERON:0000006 | 71.14 | gold quality |
| skin of leg | UBERON:0001511 | 71.05 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 71.02 | gold quality |
| right adrenal gland | UBERON:0001233 | 70.92 | gold quality |
| left adrenal gland | UBERON:0001234 | 70.84 | gold quality |
| thyroid gland | UBERON:0002046 | 70.48 | gold quality |
| heart left ventricle | UBERON:0002084 | 70.34 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 70.30 | gold quality |
| thoracic aorta | UBERON:0001515 | 70.26 | gold quality |
| ascending aorta | UBERON:0001496 | 70.21 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 70.15 | gold quality |
| metanephros cortex | UBERON:0010533 | 70.15 | gold quality |
| skin of abdomen | UBERON:0001416 | 70.10 | gold quality |
| liver | UBERON:0002107 | 70.04 | gold quality |
| ectocervix | UBERON:0012249 | 69.89 | gold quality |
| aorta | UBERON:0000947 | 69.85 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.20 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
56 targeting ZNF563, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-12129 | 99.72 | 67.45 | 1311 |
| HSA-MIR-1825 | 99.72 | 68.11 | 1089 |
| HSA-MIR-1200 | 99.71 | 70.42 | 1838 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-6516-3P | 99.65 | 68.57 | 1238 |
| HSA-MIR-875-3P | 99.63 | 69.47 | 2548 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-488-3P | 99.61 | 68.79 | 1731 |
| HSA-MIR-1260A | 99.61 | 66.67 | 1098 |
| HSA-MIR-1260B | 99.61 | 66.67 | 1098 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp961 | ENSMUSG00000052446 |
| rattus_norvegicus | Zfp617 | ENSRNOG00000049856 |
Paralogs (15): ZNF14 (ENSG00000105708), ZNF57 (ENSG00000171970), ZNF791 (ENSG00000173875), ZNF443 (ENSG00000180855), ZNF101 (ENSG00000181896), ZNF799 (ENSG00000196466), ZNF700 (ENSG00000196757), ZNF441 (ENSG00000197044), ZNF433 (ENSG00000197647), ZNF44 (ENSG00000197857), ZNF823 (ENSG00000197933), ZNF442 (ENSG00000198342), ZNF844 (ENSG00000223547), ZNF709 (ENSG00000242852), ZNF878 (ENSG00000257446)
Protein
Protein identifiers
Zinc finger protein 563 — Q8TA94 (reviewed: Q8TA94)
All UniProt accessions (4): A0A0C4DGQ9, Q8TA94, M0R1L6, M0R1Q6
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TA94-1 | 1 | yes |
| Q8TA94-2 | 2 |
RefSeq proteins (2): NP_001350537, NP_660319* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050329 | GLI_C2H2-zinc-finger | Family |
Pfam: PF00096, PF01352
UniProt features (16 total): zinc finger region 12, splice variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TA94-F1 | 70.27 | 0.13 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 63 (showing top):
TGGAAA_NFAT_Q4_01, chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ACACTGG_MIR199A_MIR199B, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CEBPZ_TARGET_GENES, HEY2_TARGET_GENES, PRKDC_TARGET_GENES, SUPT16H_TARGET_GENES, ZBTB12_TARGET_GENES, ZNF350_TARGET_GENES, MIR153_5P, MIR6867_5P, MIR4262
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), positive regulation of transcription by RNA polymerase II (GO:0045944), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), transcription cis-regulatory region binding (GO:0000976), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| regulation of DNA-templated transcription | 1 |
| positive regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| transition metal ion binding | 1 |
| transcription regulatory region nucleic acid binding | 1 |
| sequence-specific double-stranded DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
324 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF563 | DECR2 | Q9NUI1 | 519 |
| ZNF563 | VPS33A | Q96AX1 | 507 |
| ZNF563 | FBF1 | Q8TES7 | 507 |
| ZNF563 | SLC17A9 | Q9BYT1 | 507 |
| ZNF563 | LRTM3 | Q8NDH2 | 503 |
| ZNF563 | A0A2R8YFG2 | A0A2R8YFG2 | 500 |
| ZNF563 | ITSN2 | Q9NZM3 | 457 |
| ZNF563 | CLCN3 | P51790 | 454 |
| ZNF563 | EXOSC10 | Q01780 | 447 |
| ZNF563 | PTK6 | Q13882 | 445 |
| ZNF563 | RUVBL2 | Q9Y230 | 443 |
| ZNF563 | NALCN | Q8IZF0 | 394 |
| ZNF563 | CDH8 | P55286 | 383 |
| ZNF563 | COL9A3 | Q14050 | 383 |
| ZNF563 | A0A090J7P6 | A0A090J7P6 | 374 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP10-6 | ZNF563 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF563 | LRP4 | psi-mi:“MI:0914”(association) | 0.530 |
| SCRIB | ZNF563 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ECE1 | ZNF563 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF563 | KRTAP10-6 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (18): ZNF563 (Synthetic Lethality), SHCBP1 (Affinity Capture-MS), SORL1 (Affinity Capture-MS), LRP1B (Affinity Capture-MS), UBE2O (Affinity Capture-MS), LTBP4 (Affinity Capture-MS), ERBB2IP (Affinity Capture-MS), LRP4 (Affinity Capture-MS), HERC1 (Affinity Capture-MS), ZNF563 (Two-hybrid), LTBP4 (Affinity Capture-MS), LRP4 (Affinity Capture-MS), SORL1 (Affinity Capture-MS), SHCBP1 (Affinity Capture-MS), UBE2O (Affinity Capture-MS)
ESM2 similar proteins: A6NP11, B4DXR9, O43361, O95780, P0CJ79, P0DKX0, P17021, P17024, P17035, P51508, P52740, P52741, P58317, Q02386, Q0VGE8, Q13106, Q13360, Q13398, Q5JVG2, Q5RBQ3, Q5RES8, Q5TYW1, Q68DI1, Q68EA5, Q6NX49, Q6P9A1, Q6P9A3, Q6PDB4, Q6ZN06, Q76KX8, Q7L945, Q7Z340, Q86T29, Q8BZW4, Q8IW36, Q8N823, Q8N8Z8, Q8NEP9, Q8TA94, Q8TC21
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
87 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 78 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
657 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:12319312:C:CC | acceptor_gain | 1.0000 |
| 19:12322578:T:TA | donor_gain | 1.0000 |
| 19:12322583:A:AC | donor_gain | 1.0000 |
| 19:12322584:C:CT | donor_gain | 1.0000 |
| 19:12322588:T:C | donor_gain | 1.0000 |
| 19:12322722:CCACA:C | acceptor_gain | 1.0000 |
| 19:12322723:C:CT | acceptor_gain | 1.0000 |
| 19:12322723:C:T | acceptor_gain | 1.0000 |
| 19:12322725:C:CT | acceptor_gain | 1.0000 |
| 19:12322726:A:C | acceptor_gain | 1.0000 |
| 19:12322579:CCTTA:C | donor_loss | 0.9900 |
| 19:12322580:CTTA:C | donor_loss | 0.9900 |
| 19:12322581:TTA:T | donor_loss | 0.9900 |
| 19:12322582:TA:T | donor_loss | 0.9900 |
| 19:12322583:A:C | donor_loss | 0.9900 |
| 19:12322585:TTA:T | donor_gain | 0.9900 |
| 19:12322586:TAT:T | donor_gain | 0.9900 |
| 19:12322587:A:AC | donor_gain | 0.9900 |
| 19:12322587:ATA:A | donor_gain | 0.9900 |
| 19:12322625:T:C | donor_gain | 0.9900 |
| 19:12322718:C:CT | acceptor_gain | 0.9900 |
| 19:12322730:A:C | acceptor_gain | 0.9900 |
| 19:12333492:T:TA | donor_gain | 0.9900 |
| 19:12333513:C:CA | donor_gain | 0.9900 |
| 19:12322574:ATCAT:A | donor_gain | 0.9800 |
| 19:12322584:CT:C | donor_gain | 0.9800 |
| 19:12322584:CTTAT:C | donor_gain | 0.9800 |
| 19:12322600:T:TA | donor_gain | 0.9800 |
| 19:12322708:CGTC:C | acceptor_gain | 0.9800 |
| 19:12322709:GTCCT:G | acceptor_gain | 0.9800 |
AlphaMissense
3201 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:12318987:A:C | F346L | 0.993 |
| 19:12318987:A:T | F346L | 0.993 |
| 19:12318989:A:G | F346L | 0.993 |
| 19:12318819:A:C | F402L | 0.991 |
| 19:12318819:A:T | F402L | 0.991 |
| 19:12318821:A:G | F402L | 0.991 |
| 19:12319155:G:C | F290L | 0.991 |
| 19:12319155:G:T | F290L | 0.991 |
| 19:12319157:A:G | F290L | 0.991 |
| 19:12319071:A:C | F318L | 0.990 |
| 19:12319071:A:T | F318L | 0.990 |
| 19:12319073:A:G | F318L | 0.990 |
| 19:12318955:C:G | R357P | 0.988 |
| 19:12318876:G:C | H383Q | 0.985 |
| 19:12318876:G:T | H383Q | 0.985 |
| 19:12319323:A:C | F234L | 0.985 |
| 19:12319323:A:T | F234L | 0.985 |
| 19:12319325:A:G | F234L | 0.985 |
| 19:12318888:G:C | S379R | 0.983 |
| 19:12318888:G:T | S379R | 0.983 |
| 19:12318890:T:G | S379R | 0.983 |
| 19:12319044:G:C | H327Q | 0.981 |
| 19:12319044:G:T | H327Q | 0.981 |
| 19:12318780:G:C | H415Q | 0.978 |
| 19:12318780:G:T | H415Q | 0.978 |
| 19:12322677:A:G | F13S | 0.977 |
| 19:12318948:G:C | H359Q | 0.976 |
| 19:12318948:G:T | H359Q | 0.976 |
| 19:12319032:G:C | H331Q | 0.976 |
| 19:12319032:G:T | H331Q | 0.976 |
dbSNP variants (sampled 300 via entrez): RS1000038023 (19:12337734 G>A,C), RS1000062457 (19:12331496 A>G), RS1000111014 (19:12343360 C>G), RS1000127552 (19:12337322 C>T), RS1000478619 (19:12317848 A>T), RS1000508650 (19:12336079 T>TA), RS1000514034 (19:12317663 A>G), RS1000598699 (19:12330567 A>G), RS1000656626 (19:12324418 C>T), RS1000682942 (19:12349032 A>AG), RS1000745243 (19:12318129 A>G), RS1000752312 (19:12330981 A>G), RS1000828463 (19:12323159 G>C), RS1000905347 (19:12347757 A>G), RS1000937230 (19:12330191 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression, increases mutagenesis | 3 |
| dicrotophos | decreases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | affects methylation, increases abundance | 1 |
| Nitrogen Dioxide | affects methylation, increases abundance | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | affects methylation, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.